User talk:Dougtischler

Welcome!

Hello,, and welcome to Wikipedia! Thank you for your contributions. I hope you like the place and decide to stay. Here are some pages that you might find helpful: I hope you enjoy editing here and being a Wikipedian! Please sign your name on talk pages using four tildes ( ~ ); this will automatically produce your name and the date. If you need help, check out Questions, ask me on my talk page, or place  on your talk page and someone will show up shortly to answer your questions. Again, welcome! David Ruben Talk 13:44, 17 October 2006 (UTC)
 * The five pillars of Wikipedia
 * How to edit a page
 * Help pages
 * Tutorial
 * How to write a great article
 * Manual of Style

Voriconazole
Lots of good information added, but styling I think was wrong for a general encyclopaedia (vs a scientific review that might appear in a journal). I've shortened the discussion of the various papers a little and tweaked the layout. Also added PubMed abstract links to the papers.

If one can find the PubMed Abstract number, (PubMed search is at http://www.ncbi.nlm.nih.gov/entrez/query.fcgi), then Dibberi's tool (http://diberri.dyndns.org/wikipedia/templates/) may be used to autogenerate the Template:Cite journal markup which one can be copied & pasted into the article. For details on using the cite.php footnotes system (one of several methods in wikipedia), see WP:FOOTNOTES. David Ruben Talk 13:44, 17 October 2006 (UTC)

Renal cell carcinoma
Thanks for your recent edits to the renal cell carcinoma page. You significantly improved the article. If you don't mind, however, I would like your help making a further change. You used two acronyms I'm unfamiliar with, and I fear other readers may be similarly confounded by them. Would you mind adding the unabbreviated versions? The acronyms I'm referring to are "TRK" and "RTK". Here are the sentences where you used them:


 * Sorafenib (Nexavar) was FDA approved in December 2005 for treatment of advanced renal cell cancer, the first TRK indicated for this use.


 * Recently the first Phase III study comparing an RTK with cytokine therapy was published in the New England Journal of Medicine. —PHaze 01:53, 25 May 2007

I saw your clarification. Thanks! —PHaze 22:52, 29 May 2007 (UTC)